Current Pharmaceutical Design

Journal

Publication Venue For

  • Positive crossmatch kidney transplantation: State of the art and future perspectives.  26:3460-3467. 2020
  • Thrombolytic therapy in the current era: Myocardial infarction and beyond.  24:414-426. 2018
  • Micro-RNA profiling as a predictor of clinical outcomes for head and neck cancer patients.  23:4729-4744. 2017
  • Gender based differences in stress-induced gastric ulcer formation and its regulation by nitric oxide (No): An experimental study.  21:3395-3401. 2015
  • Oxytocin-a multifunctional analgesic for chronic deep tissue pain.  21:906-913. 2015
  • Leptin-induced endothelial dysfunction: A target for therapeutic interventions.  20:603-608. 2014
  • Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression.  19:1898-1922. 2013
  • Glioma stem cell maintenance: The role of the microenvironment.  17:2386-2401. 2011
  • Molecular targeted approaches for treatment of pancreatic cancer.  17:2221-2238. 2011
  • Pharmacological Activation of p53 in Cancer Cells.  17:631-639. 2011
  • Adenosine metabolism in Toxoplasma gondii: Potential targets for chemotherapy.  13:581-597. 2007
  • Editorial: Potential targets for the rational design of antiparasitic drugs.  13:553-554. 2007
  • The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure.  10:2525-2533. 2004
  • Therapeutic manipulation of the immune system: Enhancement of innate and adaptive mucosal immunity.  9:1965-1972. 2003
  • Trends in the design of nucleoside analogues as anti-HIV drugs.  8:581-593. 2002
  • International Standard Serial Number (issn)

  • 1381-6128
  • Electronic International Standard Serial Number (eissn)

  • 1873-4286